Charles River Laboratories International Inc. closed 60.67% short of its 52-week high of $254.15, which the company achieved ...

The U.S. Food and Drug Administration said on Thursday that it will be phasing out animal testing requirement for monoclonal ...

Barclays lowered the firm’s price target on Charles River (CRL) to $145 from $160 and keeps an Equal Weight rating on the shares as part of a ...

TD Cowen analyst Charles Rhyee reiterated a Hold rating and $179 price target on Charles River (CRL), saying the firm expects the FDA’s plan to ...

FibroBiologics expects its Houston manufacturing lab to increase the company's pace of discovering therapeutics and potential ...

Portuguese biotech FairJourney Biologics has acquired South San Francisco antibody R&D facility from Charles River Labs, ...

Shares of Inotiv (NASDAQ:NOTV) and Charles River Laboratories (NYSE:CRL) plummeted 49.5% and 28.1% respectively in today’s trading session. The steep decline comes on the heels of a landmark ...

The S&P 500 dropped 3.5% on Thursday, April 10, 2025, with the strong rally for stocks in the previous session running out of ...

Learn more about whether Avantor, Inc. or Charles River Laboratories International, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned an average rating of ...

Shares of Charles River Laboratories International Inc. shed 7.80% to $123.61 Tuesday, on what proved to be an all-around ...

This was the stock's third consecutive day of losses.